The Infection and Immunity Research group offers a number of technologies and capabilities to researchers, collaborators and industry partners.
Epithelial cell models
Our lung and nasal epithelial cell models could contribute to your vaccine, probiotic, bacteriophage, antiviral, or immune modulatory therapy research. Contact Professor Kirsten Spann.
Robust cell and animal models
To discuss how our cell and animal models could contribute to your research or evaluate your therapeutic target, contact Associate Professor Makrina Totsika.
Sexually transmitted disease animal models
Industry and academic researchers can access our animal models:
- Group B streptococcus challenge models
- Chlamydia and herpes models (mouse and guinea pig)
Advanced microbial analysis
Microbial description techniques
- Cellular infection models
- Real time PCR
- Mass spectrometry
- Next generation sequencing
We are currently using these techniques to characterize the microbiome of wounds, eye, gut, reproductive and respiratory systems. To discuss how our microbe description techniques could contribute to your research or evaluate your therapeutic target, contact Professor Flavia Huygens.
Microbiome characterization skills
Clinicians and pathologists seeking to examine their archival samples, please contact Dr Elise Pelzer.
Ureaplasma spp. testing of clinical samples
We have expertise in culturing, serotyping, molecular analysis and antimicrobial susceptibility profiling of human Ureaplasma spp. from clinical samples. For more information, please contact Dr Samantha Dando.
Academic researchers and industry partners can access our expertise in molecular virology and viral propagation. For more information, please contact Professor Kirsten Spann.
Neuroimmunology and ocular immunology techniques
Academic researchers, clinicians and industry partners can access our animal models and expertise in tissue dissections (brain and eye), microscopy, flow cytometry and isolation of immune cell subsets from brain and eye tissue. For more information, please contact Dr Samantha Dando.
Public health advisory
Mosquito-borne virus surveillance
To discuss collaborating or learning mosquito-borne virus surveillance, evolution or risk modeling, please contact Dr Francesca Frentiu.
In vivo retinal imaging system
We collaborate with external groups to perform in vivo multimodal retinal imaging (Micron IV) in a range of experimental mouse models of ocular disease. For more information, please contact Dr Samantha Dando.
Databases and strain banks
Access our polysaccharide capsule databases
Researchers, clinicians, public health professionals, and hospital infection control units seeking to type bacterial strains using the genomic loci involved in the synthesis of polysaccharides such as the capsule or O antigen are welcome to access the database or contact Dr Johanna Kenyon.
Access or contribute to the Acinetobacter baumannii strain bank
A strain bank is being established to hold A. baumannii strains representative of each identified capsule polysaccharide type. Researchers wanting to examine specific strains, test pharmaceutical targets, or evaluate potential phage therapies can request strains by contacting Dr Johanna Kenyon. We encourage researchers to contribute to our open access strain bank.
Chlamydia strain bank
We maintain a comprehensive Chlamydia strain bank for testing therapeutics, diagnostics or vaccines. For information on how to access these please contact Professor Ken Beagley.
Clinical bacterial strain bank
We currently house a comprehensive collection of clinical bacterial strains that can be accessed to test therapeutics and develop diagnostics. For more information please contact Professor Flavia Huygens.